digital health companies glp-1 weight loss The Impact of Agonists on the MedTech Sector: Articulating a continued value proposition for devices Impact of GLP-1 Weight Loss
Description
Semaglutide (Wegovy) is available in a weekly injectable form for weight loss
89.American Diabetes Association Professional Practice C
Vision loss and other eye-related side effects from Ozempic are serious concerns that require immediate attention
However, this structure also requires careful design to ensure the benefit remains a lifestyle reimbursement program rather than a regulated health plan
Search terms included obesity and GLP-1, and the search was limited to clinical trials published in English
